Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. (Q45722521)
Jump to navigation
Jump to search
scientific article published in July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. |
scientific article published in July 2003 |
Statements
Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type (English)
Sing-fai Leung
Anthony T C Chan
Lisa Y S Chan
Philip J Johnson
Y M Dennis Lo